Early Marker
whole-blood genomic profiling
for early disease detection.
Co-founded by Sadık and Erdal. Early Marker develops integrated wet-lab and computational systems for whole-blood genomic profiling. We detect cancer and neurodegenerative diseases at early stages by maximizing the sensitivity and specificity of cell-free and circulating biomarker analysis.
Soon at Pegasus BioLabs, Dallas, TX.
Acknowledgments
Welch Foundation; Lyda Hill Department of Bioinformatics; UTSW High Risk High Impact Award; Simmons Comprehensive Cancer Center; Lung Cancer SPORE; Kidney Cancer SPORE
© 2026 Early Marker, Inc.